Finzati - Logo
IRWD logo

Ironwood Pharmaceuticals, Inc.

IRWD • Drug Manufacturers - Specialty & Generic
$4.26
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$704.84M
Growth
7.8%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 8.1%Positive free cash flow · 0.78Consistent free cash flow · 5/5Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:22 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.26
Change0.00%
Shares Out165.45M
Market Cap$704.84M
Enterprise Value$637.58M
52W Range0.81 - 5.78
Beta0.21
P/E5.43
P/S1.81
P/B-4.36
P/FCF3.70
EV/Sales1.64

Investment DNA

How strong this company looks for long-term investors

62
out of 100
Business Quality
Margins, moat, returns
64/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
81/100
Why this score▼
Stable or improving margins · 8.1%Positive free cash flow · 0.78Consistent free cash flow · 5/5Negative growth trend

Analyst view

Analyst sentiment and price target

IRWD
Analyst sentiment
Based on 30 analyst votes · 2026-09-05
63/100
Neutral
Bullish
11
Hold
16
Bearish
3
Price Target
2026-08-07
Low
$3.70
Mean
$3.70
Median
$3.70
High
$3.70

Company Overview

IPO: 2/3/2010
Industry: Drug Manufacturers - Specialty & Generic
P/B i: -4.36
Debt / Equity i: -2.28
Operating Margin: 40.10%
Net Margin: 8.11%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: -2.28
Current Ratio: 1.13
Quick Ratio: 1.13
Status: Moderate

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Silber Jeffrey
Transaction: 07/20/2026
OTHER
Change
0
Price
Not reported
Filing
07/22/2026
Type
OTHER
Silber Jeffrey
Transaction: 07/20/2026
BUY
Change
+137,036
Price
Not reported
Filing
07/22/2026
Type
BUY
Silver Ronald
Transaction: 07/07/2026
SELL
Change
-127,890
Price
$4.52
Filing
07/09/2026
Type
SELL